## Clinical Diagnosis: Severe Mitral Stenosis with Hemodynamic Compromise ### Key Clinical Features **High-Yield:** This patient has classic mitral stenosis (MS) with: - History of acute rheumatic fever (most common cause in India) - Loud S1 (mobile anterior mitral leaflet) - Opening snap (abrupt cessation of leaflet motion) - Low-pitched diastolic murmur (best heard with bell, patient in left lateral position) - Atrial fibrillation (irregular pulse — common complication of MS) - Pulmonary edema (left atrial pressure elevation) - Mitral valve area 1.2 cm² = **severe MS** (normal ≥4 cm²; moderate 1.5–2.5 cm²) ### Hemodynamic Status & Intervention Threshold | Feature | Mild MS | Moderate MS | Severe MS | |---------|---------|-------------|----------| | MVA (cm²) | >2.5 | 1.5–2.5 | <1.5 | | Symptoms | None/exertional | Exertional | At rest/orthopnea | | Pulmonary edema | Rare | Possible | Common | | Intervention | Medical | Consider | Indicated | **Clinical Pearl:** Symptomatic severe MS with pulmonary edema is an **indication for intervention** (not medical management alone). ### Choice Between Valvotomy vs. Replacement **Key Point:** Percutaneous mitral balloon valvotomy (PMBV) is the **first-line interventional procedure** for suitable candidates because: 1. **Wilkins Score assessment** (echocardiography determines suitability): - Leaflet mobility, calcification, thickening, subvalvular disease - Score ≤8 = suitable for PMBV - Score >8 = consider surgical replacement 2. **Advantages of PMBV over surgery in this case:** - Avoids cardiopulmonary bypass - Preserves native valve (no prosthesis-related complications) - Lower morbidity in symptomatic, hemodynamically compromised patients - Can be repeated if restenosis occurs 3. **Contraindications to PMBV:** - Moderate-to-severe mitral regurgitation (not mentioned here) - Thrombus in left atrium (must exclude with TEE) - Severe calcification/immobility - Unfavorable anatomy **High-Yield:** The question does NOT mention MR, calcification, or LA thrombus, and the patient is symptomatic with hemodynamic compromise — **PMBV is indicated and appropriate**. ### Why Not Replacement? Mitral valve replacement is reserved for: - Failure of PMBV (restenosis after repeat attempts) - Contraindications to PMBV (severe MR, calcification, unfavorable anatomy) - Recurrent emboli despite anticoagulation In this case, PMBV should be attempted first. ### Why Not Medical Management Alone? **Warning:** Symptomatic severe MS with pulmonary edema cannot be managed medically. Diuretics and ACE inhibitors provide **temporary symptomatic relief only** but do not address the mechanical obstruction. Progressive hemodynamic deterioration will occur without valve intervention. ### Atrial Fibrillation Management **Clinical Pearl:** AF in MS requires: - Rate control (beta-blocker or calcium channel blocker) - Anticoagulation (warfarin or DOAC — though warfarin preferred in mechanical prosthesis if replacement needed later) - Rhythm control is less effective in MS due to structural atrial changes ## Summary **Percutaneous mitral balloon valvotomy** is the **most appropriate next step** because: 1. Severe symptomatic MS with hemodynamic compromise requires intervention 2. PMBV is first-line for suitable anatomy (no contraindications mentioned) 3. Avoids surgery and prosthesis-related complications in this patient 4. Can be repeated if restenosis occurs [cite:Harrison 21e Ch 297] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.